Melt&Marble, a Swedish BioTech scale-up specializing in precision fermentation for “designer fats”, has raised €7.3 million in Series A funding. The new investment will support scaling production and launching its first ingredients for market use. These ingredients aim to improve functionality, taste, and health outcomes in personal care and food products.
The funding round was led by Industrifonden, a Swedish DeepTech investor, with participation from the European Innovation Council (EIC) Fund and strategic partners Beiersdorf and Valio. Additional backing came from Chalmers Ventures and Catalyze Capital. The EIC Accelerator contributed an extra €2.5 million last year, bringing total funding to €10 million over 12 months.
Founded in 2014 in Gothenburg, Melt&Marble’s latest funding marks a key milestone. It validates the company’s technology platform and shows industry confidence in its commercial strategy. The investment brings together venture capital, industry, and European innovation experts, supporting the company’s growth.
CEO Anastasia Krivoruchko said, “This investment is a major step from R&D to commercialization. We’re confident in our ability to deliver sustainable, high-performance ingredients.”
Tobias Elmquist from Industrifonden added, “Melt&Marble’s technology addresses a growing demand for functional fats. We’re proud to support their journey toward market-ready, sustainable solutions.”
The global market for oils, fats, and lipids is valued at over $100 billion, covering personal care, food, and alternatives to animal fats. Melt&Marble’s platform offers animal-free fats that improve texture, bio-activity, and sustainability, meeting rising consumer expectations.
The company plans to launch its first ingredients in personal care by 2026 and expand into food markets in the US. Industry collaborations and product co-development are already underway to accelerate market entry.
